{
  "trial_id": "NCT02220894",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, race, ECOG performance status, smoking status, PD-L1 tumor proportion score (TPS), histology (squamous vs. non-squamous), prior adjuvant/neoadjuvant therapy, organ function parameters (e.g., liver function tests, renal function tests), baseline tumor measurements, comorbidities, prior radiation therapy, prior surgery, baseline weight, baseline height, baseline body mass index (BMI).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)",
          "ECOG performance status"
        ],
        [
          "Programmed Cell Death-Ligand 1 (PD-L1) Tumor Status",
          "PD-L1 tumor proportion score (TPS)"
        ],
        [
          "Tumor Histology",
          "histology (squamous vs. non-squamous)"
        ]
      ],
      "remaining_reference_features": [
        "Male"
      ],
      "remaining_candidate_features": [
        "smoking status",
        "prior adjuvant/neoadjuvant therapy",
        "organ function parameters (e.g., liver function tests, renal function tests)",
        "baseline tumor measurements",
        "comorbidities",
        "prior radiation therapy",
        "prior surgery",
        "baseline weight",
        "baseline height",
        "baseline body mass index (BMI)"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, ECOG Performance Status, Smoking History, Histology (Squamous/Non-Squamous), PD-L1 Tumor Proportion Score (TPS), Prior Systemic Therapy, Baseline Tumor Size, Organ Function (e.g., liver, kidney),",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)",
          "ECOG Performance Status"
        ],
        [
          "Programmed Cell Death-Ligand 1 (PD-L1) Tumor Status",
          "PD-L1 Tumor Proportion Score (TPS)"
        ],
        [
          "Tumor Histology",
          "Histology (Squamous/Non-Squamous)"
        ]
      ],
      "remaining_reference_features": [
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Smoking History",
        "Prior Systemic Therapy",
        "Baseline Tumor Size",
        "Organ Function (e.g., liver, kidney)"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Histology (Squamous/Non-Squamous), Smoking Status, Prior Chemotherapy, Prior Radiation Therapy, Tumor Proportion Score (TPS), PD-L1 Expression, Eastern Cooperative Oncology Group (ECOG) Performance Status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)",
          "ECOG Performance Status"
        ],
        [
          "Programmed Cell Death-Ligand 1 (PD-L1) Tumor Status",
          "PD-L1 Expression"
        ],
        [
          "Tumor Histology",
          "Histology (Squamous/Non-Squamous)"
        ]
      ],
      "remaining_reference_features": [
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Smoking Status",
        "Prior Chemotherapy",
        "Prior Radiation Therapy",
        "Tumor Proportion Score (TPS)",
        "Eastern Cooperative Oncology Group (ECOG) Performance Status."
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, ECOG Performance Status, smoking history, tumor histology, tumor stage, PD-L1 expression level, prior systemic chemotherapy, prior radiation therapy, prior malignancy, organ function (renal, hepatic, etc.), body mass index (BMI).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) Performance Status (PS)",
          "ECOG Performance Status"
        ],
        [
          "Programmed Cell Death-Ligand 1 (PD-L1) Tumor Status",
          "PD-L1 expression level"
        ],
        [
          "Tumor Histology",
          "tumor histology"
        ]
      ],
      "remaining_reference_features": [
        "Male"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "smoking history",
        "tumor stage",
        "prior systemic chemotherapy",
        "prior radiation therapy",
        "prior malignancy",
        "organ function (renal, hepatic, etc.)",
        "body mass index (BMI)"
      ]
    }
  }
}